Table 1 Summary clinical table
| Â | NCH (n = 171) | CAL (n = 145) | p | Sorlie (n = 85) | p | Porter (n = 44) | p |
|---|---|---|---|---|---|---|---|
ER+ | 113 (66%) | 96 (66%) | Â | 56 (76%) | Â | 29 (66%) | Â |
ER- | 57 (34%) | 49 (34%) | 1 | 18 (24%) | 0.176 | 15 (34%) | 1 |
Grade | Â | Â | Â | Â | Â | Â | Â |
I | 41 (24%) | 16 (11%) | Â | 9 (12%) | Â | 12 (27%) | Â |
II | 57 (34%) | 56 (40%) | Â | 33 (44%) | Â | 23 (52%) | Â |
III | 72 (42%) | 69 (49%) | 0.014 | 33 (44%) | 0.063 | 9 (20%) | 0.016 |
LN+ | 51 (30%) | 74 (51%) | Â | 53 (70%) | Â | 11 (28%) | Â |
LN- | 120 (70%) | 71 (49%) | 0.0001 | 23 (30%) | <10-8 | 25 (62%) | 1 |
Age | 58 (57.1) | 53 (55.4) | 0.075 | 57 (57.8) | 0.692 | 61 (59.5) | 0.07 |
Size (cm) | 1.8 (1.9) | 2.2 (2.4) | 0.0003 | NA | Â | 2 (2.4) | 0.67 |
≤ 1 | 12 (7%) | 8 (6%) |  | NA |  | 9 (22%) |  |
> 1, ≤ 2 | 109 (64%) | 64 (45%) |  | NA |  | 14 (34%) |  |
> 2, ≤ 5 | 49 (29%) | 65 (46%) |  | NA |  | 13 (32%) |  |
> 5 | 0 (0%) | 5 (3%) | 0.003 | NA | Â | 5 (11%) | < 10-6 |
NPI | 4.3 (3.9) | 4.5 (4.7) | < 10-7 | NA | Â | NA | Â |
< 3 | 34 (20%) | 8 (6%) | Â | NA | Â | NA | Â |
> 3, < 4 | 43 (25%) | 22 (16%) | Â | NA | Â | NA | Â |
> 4, < 5 | 65 (38%) | 50 (36%) | Â | NA | Â | NA | Â |
> 5 | 28 (16%) | 58 (42%) | < 10-6 | NA | Â | NA | Â |
Therapy | Â | Â | Â | Â | Â | Â | Â |
None | 79 (47%) | 16 (11%) | Â | 0 (0%) | Â | NA | Â |
HT or CT | 89 (53%) | 128 (89%) | < 10-11 | 85 (100%) | < 10-16 | NA | Â |